ArticleFrontiers in physiology2026
Visible-light-triggered BMP-2 release from enzymatically crosslinked marine collagen-alginate hydrogel blends enhances osteogenesis in dental pulp stem cells.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Achieving spatiotemporal control over osteoinductive signaling remains a key challenge in craniofacial tissue engineering. Conventional BMP-2 delivery from photocrosslinked hydrogels often leads to uncontrolled burst release and cytotoxic by-products from radical initiators. Here, we designed an enzymatically crosslinked marine collagen-alginate hydrogel blend that enables visible-light-triggered, on-demand release of BMP-2 while promoting oxygen diffusion through leachable porosity. Methods: Marine collagen functionalized with thiol groups (collagen-SH) was crosslinked by microbial transglutaminase (mTG) under physiological conditions, avoiding light-initiated polymerization. Recombinant BMP-2 was conjugated via a coumarin-based 405 nm-cleavable linker (BMP-2_pc) and covalently tethered to the collagen network. Non-crosslinked sodium alginate (0.6% w/v) was incorporated as a sacrificial porogen to create micropores upon diffusion. DPSC were encapsulated (1.5 × 10 Results: Blue-light stimulation induced stepwise BMP-2 release (≈23% per pulse; 60% cumulative at 72 h), while mTG crosslinking preserved coumarin integrity. Alginate leaching generated an interconnected microporosity (20-60 µm pores) and increased oxygen diffusion coefficient by 42% ± 9%. DPSC viability remained >90%. Light-pulsed composites exhibited 2.4-fold ALP activity and 2.8-fold higher mineral deposition versus dark controls (p < 0.01). Conclusion: The orthogonally crosslinked marine collagen-alginate composite supports visible-light-controlled BMP-2 delivery and oxygen-enhanced osteogenesis without photoinitiator toxicity. This platform provides a modular, sustainable route toward clinically programmable scaffolds for dental and craniofacial regeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.